Skip to main navigation
Skip to search
Skip to main content
Mayo Clinic Home
Home
Profiles
Departments/Divisions
Grants
Research output
Prizes
Search by expertise, name or affiliation
How I treat myelofibrosis after failure of JAK inhibitors
Animesh Pardanani
,
Ayalew Tefferi
Hematology
Research output
:
Contribution to journal
›
Article
›
peer-review
14
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'How I treat myelofibrosis after failure of JAK inhibitors'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Janus Kinase Inhibitors
68%
Primary Myelofibrosis
61%
INCB018424
21%
Investigational Drugs
9%
Transplants
8%
Salvage Therapy
8%
Therapeutics
8%
Splenomegaly
7%
Opportunistic Infections
7%
Splenectomy
7%
Cytogenetics
6%
Stem Cells
5%
Radiotherapy
4%
Quality of Life
4%
Mutation
3%
Chemical Compounds
Ruxolitinib
100%
Cytogenetics
34%
Mutation
20%
Drug
12%
Reduction
11%